To evaluate whether this phenomenon may occur, tumor-bearing animals were administered anti-CD40L at the same time as the photoimmunotherapy treatment, in order to suppress the possible priming of new effector T cells that could result from photoimmunotherapy treatment. The gene discussed is CD40LG; the disease is neoplasm.